A Step-by-Step Guide for Biosynthesis of Recombinant Fusion Antimicrobial Peptide and Release of the Active Peptide from Its Fusion Partner by Formic Acid Cleavage
View abstract on PubMed
Summary
This summary is machine-generated.This study details a cost-effective method for producing short peptides using recombinant fusion in Escherichia coli. Formic acid cleavage simplifies purification, yielding 6.5 mg/L of active peptide.
Area Of Science
- Biotechnology
- Molecular Biology
- Protein Chemistry
Background
- Recombinant protein production is crucial for peptide therapeutics.
- Traditional peptide purification methods can be complex and costly.
- Fusion partners are often used to facilitate peptide expression and purification.
Purpose Of The Study
- To present a simplified protocol for cloning and expressing short peptides as fusion proteins.
- To demonstrate the efficacy of formic acid cleavage for releasing active peptides.
- To optimize the purification and characterization of recombinant peptides.
Main Methods
- Gene cloning of short peptides with a fusion partner.
- Biosynthesis of recombinant fusion peptide in Escherichia coli.
- Peptide separation via formic acid cleavage, purification, and characterization.
Main Results
- A cost-effective method for releasing active peptides from fusion partners was established.
- The procedure simplifies peptide purification by avoiding denaturant removal steps.
- Achieved a yield of 6.5 mg/L of recombinant fusion peptide.
Conclusions
- Formic acid cleavage offers an advantageous alternative to enzymatic cleavage for peptide release.
- This protocol streamlines recombinant peptide production, reducing time and labor.
- The method is effective for producing purified short peptides, though challenges in acid digestion are noted.

